Below is a list of common side effects associated with GLP-1 receptor agonists, as noted by the FDA-issued package inserts for approved GLP-1 medications: Decreased Appetite: Many users experience a reduced desire to eat, which can aid in weight loss
a Therapeutic Use Exemption may apply on a case-by-case basis for athletes with medically documented need, but TUE is not automatic and is not granted purely on the basis of an approved indication
For those without insurance or adequate coverage, a SingleCare prescription discount card may help reduce the retail costs of the medications
Polysomnography confirmed higher sleep efficiency and shorter sleep latency with DSIP compared to placebo
Only semaglutide is available as an oral medication (under the brand name Rybelsus)
Semaglutide injections are $189/mo month-to-month, or from $149/mo on the 6-month plan, with HSA and FSA account eligibility, making personalized GLP-1 therapy affordable and accessible